id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-278174-znc99yos	Ramsey, Glenn	Managing recalls and withdrawals of blood components	2004-01-31		.txt	text/plain	4900	251	49	Abstract Donor centers are issuing a growing number of recalls and market withdrawals to hospital transfusion services about blood components. Using the FDA's categories of donor center biological product deviations, we provide recommendations to consider for when to notify the recipient's physician, after postdonation information is received about a previously transfused blood component. If a blood product has been transfused from a donor who should have been ineligible at the time of donation, then "we recommend that the establishments consider notifying the treating physician of those recipients about the post donation information, including whether the donor developed suspected SARS." Donors are deferred for 28 days after recovering from suspected SARS or for 14 days after exposure to a person with SARS or travel to SARS-risk areas.	./cache/cord-278174-znc99yos.txt	./txt/cord-278174-znc99yos.txt